To receive daily emails from Breaking Christian News to your inbox CLICK HERE
Drug Developed in Israel Saves 47 of 50 Severe Covid Patients in TrialBonus BioGroup says its MesenCure experimental treatment resulted in 94% survival rate of trial subjects and cut hospitalization time in half. [ISRAEL21c.org] Israel's Bonus BioGroup reports a survival rate of 94 percent (47 of 50) of the severe Covid-19 patients treated with its drug product MesenCure in a Phase II, multicenter clinical trial. (Image: Illustrative photo of Covid-19 patient at Kaplan Medical Center in Rehovot, one of three Israeli hospitals that participated in Phase II trials of MesenCure by Bonus BioGroup. /Credit: Yossi Aloni-Flash90 /via ISRAEL21c.org) Study results, soon to be published, show MesenCure treatment reduced study participants' hospitalization period by about half compared to a control group. All these patients had life-threatening pneumonia and respiratory distress caused by Covid-19. The data shows that MesenCure treatment reduced mortality by about 70% compared with the control group. Only two of the first 30 severe Covid-19 patients treated with MesenCure died due to Covid-19 or its complications, while 14 of 60 similar patients in the control group died. MesenCure treatment shortened the hospitalization period of severe Covid-19 patients by eight days on average, a reduction of 45% relative to the control group. The experimental group included women and men aged 41.4 to 77.4. About 77% of the severe Covid-19 patients treated in three hospitals with MesenCure had one or more risk factors for poor prognosis: hypertension, hyperlipidemia, obesity and Type 2 diabetes. Most were treated during the fourth Covid-19 wave in Israel, dominated by the Delta strain. The control group received the current standard of care — anti-inflammatory drugs in combination with steroids. This regimen, according to Bonus BioGroup, reduces mortality in hospitalized Covid-19 patients only slightly, from 25.8% to 21.8%, indicating that MesenCure is four times more effective. "We are proud of our success in leading the world to be a safer place by developing a medication for severe Covid-19 patients, thereby dramatically reducing the threat to their lives," said Dr. Shai Meretzki, CEO of Bonus BioGroup. "In less than two years from the epidemic outbreak, we are the first in the world to report an effective and significant treatment for severely ill patients." According to a statement from Bonus BioGroup, an independent expert committee confirmed the findings of the Phase II clinical trial of MesenCure and recommended continuing toward Phase III. Meretzki told the Jerusalem Post that the company will apply for emergency use approval from European and US regulatory agencies. Subscribe for free to Breaking Christian News here
To receive daily emails from Breaking Christian News to your inbox CLICK HERE Other Recent Articles from Breaking Christian News California Town Tears Down Beloved Hillside Cross Danielle Smith Again Defends Alberta's Coming Ban on Transgender Mutilation of Children US Supreme Court Says Idaho Can Enforce Ban on Child 'Sex Changes' as Lawsuit Continues How Bidenomics Shattered the American Dream of Homeownership Bill Aims to Stop Illegal Aliens from Squatting in US Homes Soros-Linked NGO Distributes Flyers in Mexico Telling Illegal Immigrants to 'Vote For Biden': Report Long-Awaited Articles of Impeachment against DHS Secretary Mayorkas Finally Arrive in Senate Justices Gorsuch and Alito Highlight Biden Admin's Glaring Double Standard during J6 Hearing NPR Suspends Editor Who Blew Whistle on Left-Wing Takeover of Newsroom 50,000 Join Polish March for Life in the Midst of Government Push to Overturn Abortion Ban Hamas Remains Obstacle to Gaza Ceasefire, Israel Has Moved in a 'Significant Way,' US Says Wow. Joe Biden Approved Iran's Assault on Israel 'Within Certain Limits' Maine Governor Allows National Popular Vote Legislation to Become Law Election Integrity: Trump, Mike Johnson Back Bill Assuring Only US Citizens Vote in Elections Fox News Host Lawrence Jones Delivers Powerful Gospel Message: I'm 'Proud to Be a Believer' California Mom Wants Child Castrated Without Father's Consent Search the Articles Archives |
All articles on this site and emails from BCN are copyrighted property of Breaking Christian News. Permission is given to link to, or share a BCN story if proper attribution is given to both the original writer and summarizer of the story. Breaking Christian News 2005-2019. All Rights Reserved.
Breaking Christian News is a division of Elijah List Publications, Inc. All Rights Reserved
Disclaimer: Articles and links, as well as the source articles linked to; do not necessarily reflect the opinion of Breaking Christian News.
Home | Store | Subscribe | Facebook | Article Archive |